Quest Diagnostics
DGX----
Q2 FY2026 EarningsQ2 FY26 revenue reached $3.04B, up 10.2% YoY, with 10.0% organic growth driven by strong requisition volume (+13.1%). Adjusted diluted EPS grew 19.1% YoY to $3.12. Operating income was $459M (15.1% margin), while adjusted operating margin stood at 16.5%. Full-year 2026 guidance was raised, with revenue now expected between $11.95B-$12.05B and adjusted EPS at $11.05-$11.25.
Financial report interval: 2026.03.30 - 2026.06.30
Preview: Quest Diagnostics(DGX) predict that the Revenue is 3.043 B (+10.21%), Beat estimate;the EBIT is 502 M (+7.73%), Beat estimate;the EPS is 2.84 (+14.98%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.04B10.21%
2.97B7.67%
+0.07B2.54%
EBITExceed expectations
0.50B7.73%
0.49B4.83%
+0.01B2.90%
EPSExceed expectations
2.8414.98%
2.52742.33%
+0.312612.65%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf